BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 32915061)

  • 1. How ADA methodology informs SARS-CoV-2 assay development.
    Becker C
    Bioanalysis; 2020 Sep; 12(18):1275-1277. PubMed ID: 32915061
    [No Abstract]   [Full Text] [Related]  

  • 2. What to Expect from Antibody Assays of SARS-CoV-2?
    Yi X; Cao J
    J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
    [No Abstract]   [Full Text] [Related]  

  • 3. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
    Greene DN
    J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young Children Presenting With Fever and Rash in the Midst of SARS-CoV-2 Outbreak in New York.
    Wolfe DM; Nassar GN; Divya K; Krilov LR; Noor A
    Clin Pediatr (Phila); 2020 Oct; 59(12):1112-1118. PubMed ID: 32633553
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
    Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
    J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 diagnostic testing in Africa: needs and challenges.
    Adebisi YA; Oke GI; Ademola PS; Chinemelum IG; Ogunkola IO; Lucero-Prisno Iii DE
    Pan Afr Med J; 2020; 35(Suppl 2):4. PubMed ID: 32528615
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
    Moran A; Beavis KG; Matushek SM; Ciaglia C; Francois N; Tesic V; Love N
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303565
    [No Abstract]   [Full Text] [Related]  

  • 9. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic tests for COVID-19 detection: A hybrid methodology.
    Díaz-Badillo A; Muñoz ML; Morales-Gómez MC; Martínez-Ezquerro JD; Quispe-Siccha RM; López-Alvarenga JC
    Cir Cir; 2020; 88(5):537-541. PubMed ID: 33064682
    [No Abstract]   [Full Text] [Related]  

  • 11. Beware of False-Positive Results with SARS-CoV-2 Antibody Tests.
    Ebell MH; Barry HC
    Am Fam Physician; 2020 Jul; 102(1):5-6. PubMed ID: 32603079
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
    Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
    J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
    McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
    [No Abstract]   [Full Text] [Related]  

  • 14. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.
    Williams E; Bond K; Zhang B; Putland M; Williamson DA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317257
    [No Abstract]   [Full Text] [Related]  

  • 15. Testing for SARS-CoV-2 (COVID-19): A General Review.
    Tang EW; Bobenchik AM; Lu S
    R I Med J (2013); 2020 Sep; 103(8):20-23. PubMed ID: 32900007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of serological testing in the SARS-CoV-2 outbreak.
    Mayne ES; Scott L; Semete B; Julsing A; Jugwanth S; Mampeule N; David A; Gededzha MP; Goga A; Hardie D; Preiser W; Chetty K; Rees H; Sanne I; Mlisana K; George JA; Stevens W
    S Afr Med J; 2020 Jul; 110(9):842-845. PubMed ID: 32880264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal Swab Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab Shortage.
    Péré H; Podglajen I; Wack M; Flamarion E; Mirault T; Goudot G; Hauw-Berlemont C; Le L; Caudron E; Carrabin S; Rodary J; Ribeyre T; Bélec L; Veyer D
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32295896
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 testing.
    Ferrari R; De Angelis M
    Eur Heart J; 2020 Jul; 41(26):2427-2428. PubMed ID: 32623463
    [No Abstract]   [Full Text] [Related]  

  • 20. The COVID-19 Diagnostic Dilemma: a Clinician's Perspective.
    Rogers R; O'Brien T; Aridi J; Beckwith CG
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.